Wedbush Securities’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.27M Sell
16,203
-731
-4% -$57.2K 0.04% 345
2025
Q1
$1.23M Sell
16,934
-874
-5% -$63.3K 0.05% 332
2024
Q4
$1.32M Sell
17,808
-449
-2% -$33.2K 0.05% 299
2024
Q3
$1.21M Sell
18,257
-632
-3% -$41.7K 0.04% 320
2024
Q2
$1.75M Buy
18,889
+285
+2% +$26.3K 0.06% 227
2024
Q1
$1.78M Sell
18,604
-615
-3% -$58.8K 0.07% 234
2023
Q4
$1.47M Sell
19,219
-370
-2% -$28.2K 0.06% 230
2023
Q3
$1.36M Sell
19,589
-1,023
-5% -$70.9K 0.07% 227
2023
Q2
$1.94M Sell
20,612
-3,235
-14% -$305K 0.09% 160
2023
Q1
$1.97M Sell
23,847
-2,930
-11% -$242K 0.1% 159
2022
Q4
$2M Sell
26,777
-2,511
-9% -$187K 0.11% 144
2022
Q3
$2.42M Buy
29,288
+829
+3% +$68.5K 0.14% 118
2022
Q2
$2.71M Sell
28,459
-1,174
-4% -$112K 0.15% 111
2022
Q1
$3.49M Buy
29,633
+447
+2% +$52.6K 0.16% 102
2021
Q4
$3.78M Buy
29,186
+6,173
+27% +$800K 0.16% 97
2021
Q3
$2.61M Buy
23,013
+518
+2% +$58.6K 0.12% 130
2021
Q2
$2.33M Buy
22,495
+5,124
+29% +$531K 0.11% 156
2021
Q1
$1.45M Buy
17,371
+2,056
+13% +$172K 0.08% 232
2020
Q4
$1.4M Sell
15,315
-2,168
-12% -$198K 0.12% 181
2020
Q3
$1.4M Buy
17,483
+97
+0.6% +$7.74K 0.13% 161
2020
Q2
$1.2M Buy
17,386
+925
+6% +$64K 0.11% 184
2020
Q1
$1.04M Buy
16,461
+1,452
+10% +$91.3K 0.12% 169
2019
Q4
$1.17M Buy
15,009
+939
+7% +$73K 0.1% 211
2019
Q3
$1.03M Sell
14,070
-75
-0.5% -$5.5K 0.1% 230
2019
Q2
$871K Sell
14,145
-480
-3% -$29.6K 0.09% 260
2019
Q1
$933K Buy
14,625
+1,215
+9% +$77.5K 0.1% 234
2018
Q4
$685K Buy
13,410
+4,380
+49% +$224K 0.09% 265
2018
Q3
$524K Buy
9,030
+72
+0.8% +$4.18K 0.06% 377
2018
Q2
$435K Sell
8,958
-3,972
-31% -$193K 0.05% 420
2018
Q1
$601K Sell
12,930
-10,341
-44% -$481K 0.08% 306
2017
Q4
$874K Buy
23,271
+810
+4% +$30.4K 0.11% 230
2017
Q3
$818K Sell
22,461
-2,238
-9% -$81.5K 0.11% 221
2017
Q2
$973K Buy
24,699
+1,200
+5% +$47.3K 0.13% 197
2017
Q1
$737K Sell
23,499
-7,062
-23% -$221K 0.1% 244
2016
Q4
$955K Buy
30,561
+25,020
+452% +$782K 0.14% 170
2016
Q3
$223K Buy
+5,541
New +$223K 0.03% 626